PAF stock news
This page provides real-time market news, earnings updates, and company announcements related to Pan African Resources PLC (PAF).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 01:19 GMT
Royal Gold Gets Ready to Report Q4 Earnings: Here's What to Expect
Finviz2026-02-16 17:12:11
Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44
U.S. gold concept stocks decline
格隆汇2026-02-17 14:38:55
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Finviz2026-02-19 13:03:13
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
Finviz2026-02-19 23:00:50
WRAP Launches "Transitional Control" Training Unit in Collaboration with STORM Training Group
Finviz2026-02-20 12:33:13
Fortuna Mining (FSM) Climbs 12.6% on Higher Gold Resource
Finviz2026-02-21 16:15:42
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Finviz2026-02-23 13:03:50
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
Finviz2026-02-24 13:03:11
What's Going On With Fulcrum Therapeutics Stock Tuesday?
Finviz2026-02-24 14:51:42
PAAS Delivers Record Revenues in 2025: Can the Rally Continue?
Finviz2026-02-24 17:27:08
ARLO to Post Q4 Earnings: What's in the Cards for the Stock?
Finviz2026-02-24 17:58:01
Noodles & Company to Announce Fourth Quarter and Full Year 2025 Results on March 25, 2026
Finviz2026-02-25 14:03:10
Pan American Silver Slumps 1.62% Amid 34.42% Volume Surge to $450M Ranks 298th as Institutional Holdings Soar
101 finance2026-02-25 23:54:44
Wrap Expedites Drone-Based Non-Lethal Technologies; Strengthens Commitment with K-Form, Inc.
Finviz2026-02-26 12:33:47
IonQ Jumps 20%: Is This the Leading Force in Quantum Security Developments?
101 finance2026-02-26 18:09:52
Hundreds of Papa Johns stores are shutting down
101 finance2026-02-26 18:33:40
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Finviz2026-02-26 21:09:39
DLR Tumbles 1.79% on $350M Volume Ranks 399th in Daily Market Activity
101 finance2026-02-27 00:39:34
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
Finviz2026-02-19 23:00:50
WRAP Launches "Transitional Control" Training Unit in Collaboration with STORM Training Group
Finviz2026-02-20 12:33:13
Fortuna Mining (FSM) Climbs 12.6% on Higher Gold Resource
Finviz2026-02-21 16:15:42
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Finviz2026-02-23 13:03:50
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
Finviz2026-02-24 13:03:11
What's Going On With Fulcrum Therapeutics Stock Tuesday?
Finviz2026-02-24 14:51:42
PAAS Delivers Record Revenues in 2025: Can the Rally Continue?
Finviz2026-02-24 17:27:08
ARLO to Post Q4 Earnings: What's in the Cards for the Stock?
Finviz2026-02-24 17:58:01
Noodles & Company to Announce Fourth Quarter and Full Year 2025 Results on March 25, 2026
Finviz2026-02-25 14:03:10
Pan American Silver Slumps 1.62% Amid 34.42% Volume Surge to $450M Ranks 298th as Institutional Holdings Soar
101 finance2026-02-25 23:54:44
Wrap Expedites Drone-Based Non-Lethal Technologies; Strengthens Commitment with K-Form, Inc.
Finviz2026-02-26 12:33:47
IonQ Jumps 20%: Is This the Leading Force in Quantum Security Developments?
101 finance2026-02-26 18:09:52
Hundreds of Papa Johns stores are shutting down
101 finance2026-02-26 18:33:40
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Finviz2026-02-26 21:09:39
DLR Tumbles 1.79% on $350M Volume Ranks 399th in Daily Market Activity
101 finance2026-02-27 00:39:34
PAF stock price change
On the last trading day, PAF stock closed at 179.00 GBP, with a price change of -0.56% for the day.
Trade stock perpsPAF stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more